Comparison of a trifocal intraocular lens with a +3.0 D bifocal IOL: Results of a prospective randomized clinical trial

Abstract

Dr. Bauer received study grants from Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Physiol S.A. and a lecture fee from Alcon Surgical, Inc. Dr. Nuijts is a consultant to Alcon Surgical, Inc., Théa Pharma GmbH, and ASICO LLC; he has received study grants from Acufocus, Inc., Alcon Surgical, Inc., Carl Zeiss Meditec AG, Ophtec BV, and Physiol S.A. No other author has a financial or proprietary interest in any material or method mentioned.

A More Natural Way of Seeing: Visual Performance of Three Presbyopia Correcting Intraocular Lenses

“…This confirms the ability of the lenses to successfully restore the distance visual function, as also shown for different models of multifocal IOLs [5] [10]- [25]. A mean monocular UDVA of 0.05 ± 0.07 logMAR (decimal 0.89) was reported by Law et al [14] in patients bilaterally implanted with the ATLISA trifocal IOL.…”

“…Law et al [1] reported a mean binocular UNVA value of 0.16 ± 0.07 logRAD (decimal 0.69; measured at 40 cm) in a group of eyes implanted with the ATLISA trifocal IOL, Kohnen et al [24] reported bilateral UNVA values of 0.04 ± 0.10 (decimal 0.91) and Mojzis [5] found a monocular mean UNVA of 0.20 ± 0.12 logMAR (decimal 0.63; measured at 33 cm) with the same lens model. With the FineVision trifocal IOL, Alió et al [17] reported a mean monocular UNVA of 0.26 ± 0.15 (decimal 0.55; measured at 40 cm) and Jonker et al [25] 0.15 ± 0.13 logMAR (decimal 0.71). Mean logMAR UNVA values of 0.11 ± 0.12 (decimal 0.11; measured at 35 cm) and 0.01 ± 0.06 (decimal 0.98; measured at 35 cm) have been reported by Vryghem and Heireman [19] and Cochener et al [13].…”

“…Law et al [14] reported that a limited percentage of patients implanted with the same IOL had some difficulties to perform near and intermediate visual tasks without glasses, such as reading the newspaper or working with the computer [14]. In a study with the FineVision IOL, 80% of the patients were reported to be completely spectacle independent [25].…”

Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)

“…In their study performed on 94 eyes of 47 patients, Cochener et al [29] reported binocular UDVA, UIVA and UNVA as 0.02 ± 0.09, 005 ± 0.08 and 0.00 ± 0.04 logMAR, respectively at the 6th month following FineVision trifocal IOL implantation. Jonker et al [30] compared the Finevision Micro F trifocal IOL with the Acrysof Restor IQ C3.0 D bifocal IOL in their randomized prospective study and indicated that better defocus curve was obtained by trifocal IOL in the intermediate distance. They also reported that the mean binocular UDVA, UIVA, and UNVA were 0.01 ± 0.11 logMAR, 0.32 ± 0.15 logMAR, and 0.15 ± 0.13 logMAR, respectively, in the patients implanted with trifocal IOL (30 eyes of 15 patients) at the postoperative 6th month.…”

Clinical comparison of patient outcomes following implantation of trifocal or bifocal intraocular lenses: a systematic review and meta-analysis

“…More and more patients presenting for cataract surgery want to enjoy good vision at distance, intermediate, and near ranges without the use of spectacles. Multifocal IOLs that can provide a wide range of clear vision attempt to meet this objective12.…”